Roswell Park Set to Open Several New Trials this Year for Innovative CAR T-Cell Therapies

CAR T-cell therapies are the future of cancer treatment and Roswell Park Comprehensive Cancer Center is preparing to open a number of new trials based on research originating here and in partnership with the industry.

March 17, 2025

Roswell Park Comprehensive Cancer Center

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

#1

Roswell Park Comprehensive Cancer Center

Buffalo, NY
Key Differentiators
- Hematology
- Oncology
- Cell Therapy
- Translational Research
#2

Memorial Sloan Kettering Cancer Center

New York, NY
Key Differentiators
- Hematology
- Oncology
- Cell Therapy
- Immunotherapy
#3

Fred Hutchinson Cancer Center

Seattle, WA
Key Differentiators
- Hematology
- Oncology
- Cell Therapy
- Immunotherapy
#4

University of Pennsylvania - Abramson Cancer Center

Philadelphia, PA
Key Differentiators
- Hematology
- Oncology
- Cell Therapy
- Immunotherapy
#5

MD Anderson Cancer Center

Houston, TX
Key Differentiators
- Hematology
- Oncology
- Cell Therapy
- Immunotherapy

Roswell Park Set to Open Several New Trials this Year for Innovative CAR T-Cell Therapies

Top Institutions in Oncology

Roswell Park Comprehensive Cancer Center

Memorial Sloan Kettering Cancer Center

Fred Hutchinson Cancer Center

University of Pennsylvania - Abramson Cancer Center

MD Anderson Cancer Center

Original Source(s)

Roswell Park Set to Open Several New Trials this Year for Innovative CAR T-Cell Therapies

Related Content

From molecular networks to translational intervention: current progress in the mechanisms of gemcitabine resistance in bladder cancer

Lifestyle and Surveillance Adherence After Childhood Cancer—When Financial Hardship Shapes Survivorship

Differentiation of hepatocellular carcinoma from hepatic hemangioma using diffusion-derived vessel density map-based radiomics features